stonks (@JStonker) profile picture
Joined April 2020
Photo by stonks (@JStonker)Photo by stonks (@JStonker)Photo by stonks (@JStonker)Photo by stonks (@JStonker)Photo by stonks (@JStonker)Photo by stonks (@JStonker)Photo by stonks (@JStonker)Photo by stonks (@JStonker)Photo by stonks (@JStonker)Photo by stonks (@JStonker)
Published today - AVA6103 cited in a new peer-reviewed paper on peptide-based technology for treating PDAC by Istanbul-based researchers. #AVCT
12
93
4,085
AVA6103 covered by Pharmaceutical Observer in Shanghai this morning. m.163.com/dy/article/LBF3V98… #AVCT
2
14
1
84
3,909
AVA6103 added to the US National Cancer Institute's NCI Thesaurus on 26 October 2026, receiving its own standardised biomedical terminology entry (C229108). evsexplore.semantics.cancer.… #AVCT
3
9
93
2,922
Ongoing patent activity around #AVCT's Affimer immunotherapy platform - divisional patent application filed in May and published this morning in Japan. Serum Half-Life Prolonging PD-L1 Inhibiting Polypeptide. j-platpat.inpit.go.jp/c1801/…
1
5
57
2,491
"A number of very interesting combinations" for AVA6207. #AVCT
Replying to @tom_the_bomb__
"Any interest from big pharmas, either licensing or partnering?" "I can't disclose too much... but I would say that we're having a number of very interesting combinations, all of the pharmas out there have their own toxic drugs." Edited slightly for character limit.
4
22
1,672
Abstract published for AVA6207 at EORTC-NCI-AACR. #AVCT
17
83
2,259
"Moonshots that exist under the surface" #AVCT
1
6
90
2,971
🤞🏼 for more coverage later on. #AVCT
9
70
1,876
FAP and the TME in the spotlight at ESMO. #AVCT
8
47
1,576
CC in great company this Tuesday. More or less every major pharma attending the event too. #AVCT
1
10
1
99
7,295
CC interviewed at ESMO by Labiotech. labiotech.eu/trends-news/esm… #AVCT
1
11
1
91
7,073
AVA6103 featured in a new case study this morning by #AVCT partner CRO Sygnature Discovery sygnaturediscovery.com/case-…
2
15
2
120
9,679
#AVCT's preCISION tech covered today by Cancer Research UK's @CR_Horizons cancerresearchhorizons.com/n…
2
9
95
3,202
AVA6000 featured as an ESMO highlight on The Pharma Letter thepharmaletter.com/esmo-con… #AVCT
10
99
2,958
Very brief mention for AVA6103 today from ChemOutsourcing, a Boston-based pharma business development and sourcing event. linkedin.com/posts/new-partn… #AVCT
1
5
43
2,614